European Journal of Haematology, 1600-0609

Journal

More filtering options
  1. 2020
  2. Introducing patient-reported outcome in the acute leukemia quality registries in Sweden

    Lennmyr, E. B., Karlsson, K., Abrahamsson, M., Ebrahim, F., Lübking, A., Höglund, M., Gunnar Juliusson & Hallböök, H., 2020 Feb 20, In : European Journal of Haematology.

    Research output: Contribution to journalArticle

  3. Extracorporeal photopheresis for graft-vs-host disease: A literature review and treatment guidelines proposed by the Nordic ECP Quality Group

    Nygaard, M., Stina Wichert, Berlin, G. & Toss, F., 2020, In : European Journal of Haematology. 104, 5, p. 361-375 15 p.

    Research output: Contribution to journalReview article

  4. Outcome and characteristics of non-measurable myeloma: A cohort study with population-based data from the Swedish Myeloma Registry

    Wålinder, G., Samuelsson, J., Näsman, P., Markus Hansson, Gunnar Juliusson, Forsberg, K., Svensson, R., Linder, O., Carlson, K., Kristinsson, S. Y., Mellqvist, U. H., Hveding Blimark, C., Ingemar Turesson & Nahi, H., 2020, In : European Journal of Haematology. 104, 5, p. 376-382 7 p.

    Research output: Contribution to journalArticle

  5. 2019
  6. Clinical utility and impact of the use of the chromogenic vs one-stage factor activity assays in haemophilia A and B

    Marlar, R. A., Strandberg, K., Shima, M. & Adcock, D. M., 2019 Oct 13, In : European Journal of Haematology.

    Research output: Contribution to journalReview article

  7. The red blood cell count and the erythrocyte sedimentation rate in the diagnosis of polycythaemia vera

    Nersesjan, V., Kristoffer A Zervides, Sørensen, A. L., Kjaer, L., Skov, V. & Hasselbalch, H. C., 2019 Oct 4, In : European Journal of Haematology. p. 1-9

    Research output: Contribution to journalArticle

  8. Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication, and strategies for difficult-to-treat patients

    Rolf Ljung, Auerswald, G., Benson, G., Dolan, G., Duffy, A., Hermans, C., Jiménez-Yuste, V., Lambert, T., Morfini, M., Zupančić-Šalek, S. & Santagostino, E., 2019 Feb, In : European Journal of Haematology. 102, 2, p. 111-122

    Research output: Contribution to journalReview article

  9. Highly reduced survival in essential thrombocythemia and polycythemia vera patients with vascular complications during follow-up

    Ahlstrand, E., Samuelsson, J., Lindgren, M., Pettersson, H., Liljeholm, M., Ravn-Landtblom, A., Stefan Scheding & Andréasson, B., 2019, In : European Journal of Haematology.

    Research output: Contribution to journalArticle

  10. 2018
  11. Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer survival

    Ingemar Turesson, Bjorkholm, M., Blimark, C. H., Kristinsson, S., Velez, R. & Landgren, O., 2018 Aug 1, In : European Journal of Haematology. 101, 2, p. 237-244 8 p.

    Research output: Contribution to journalReview article

  12. Low response rate to ATG-based immunosuppressive therapy in very severe aplastic anaemia - A Swedish nationwide cohort study

    Vaht, K., Göransson, M., Carlson, K., Isaksson, C., Lenhoff, S., Sandstedt, A., Uggla, B., Winiarski, J., Ljungman, P., Brune, M. & Andersson, P. O., 2018, In : European Journal of Haematology. 100, 6, p. 613-620

    Research output: Contribution to journalArticle

  13. 2017
  14. Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis

    Moreau, P., Dimopoulos, M. A., Richardson, P. G., Siegel, D. S., Cavo, M., Corradini, P., Weisel, K. C., Delforge, M., O'Gorman, P., Song, K., Chen, C., Bahlis, N., Oriol, A., Hansson, M., Kaiser, M., Anttila, P., Raymakers, R., Joao, C., Cook, G., Sternas, L. & 7 others, Biyukov, T., Slaughter, A., Hong, K., Herring, J., Yu, X., Zaki, M. H. & San Miguel, J., 2017 Sep 1, In : European Journal of Haematology. 99, 3, p. 199-206 8 p.

    Research output: Contribution to journalArticle

  15. Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register

    Nahi, H., Genell, A., Wålinder, G., Uttervall, K., Gunnar Juliusson, Karin, F., Markus Hansson, Svensson, R., Linder, O., Carlson, K., Björkstrand, B., Kristinsson, S. Y., Mellqvist, U-H., Blimark, C. & Ingemar Turesson, 2017 Sep, In : European Journal of Haematology. 99, 3, p. 216-222

    Research output: Contribution to journalArticle

  16. Age but not Philadelphia positivity impairs outcome in older/elderly patients with acute lymphoblastic leukemia in Sweden

    Kozlowski, P., Lennmyr, E., Ahlberg, L., Bernell, P., Hulegårdh, E., Karbach, H., Karlsson, K., Tomaszewska-Toporska, B., Åström, M., Hallböök, H. & the Swedish Adult Acute Lymphoblastic Leukemia Group (SVALL), 2017 Aug 1, In : European Journal of Haematology. 99, 2, p. 141-149 9 p.

    Research output: Contribution to journalArticle

  17. Outcome measures for adult and pediatric hemophilia patients with inhibitors

    Hermans, C., Auerswald, G., Benson, G., Dolan, G., Duffy, A., Jiménez-Yuste, V., Rolf Ljung, Morfini, M., Lambert, T., Mehdi Osooli & Zupančić Šalek, S., 2017 Aug 1, In : European Journal of Haematology. 99, 2, p. 103-111 9 p.

    Research output: Contribution to journalReview article

  18. Genomewide association study on monoclonal gammopathy of unknown significance (MGUS)

    Hauke Thomsen, Campo, C., Weinhold, N., da Silva Filho, M. I., Pour, L., Gregora, E., Vodicka, P., Vodickova, L., Hoffmann, P., Nöthen, M. M., Jöckel, K-H., Langer, C., Hajek, R., Goldschmidt, H., Kari Hemminki & Asta Försti, 2017 Jul, In : European Journal of Haematology. 99, 1, p. 70-79 10 p.

    Research output: Contribution to journalArticle

  19. The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany

    Berntorp, E., Dargaud, Y., Hart, D. P., Lobet, S., Mancuso, M. E., d'Oiron, R., Perry, D., Pollard, D., van den Berg, M., Blatný, J., Chambost, H., Doria, A. S., Holme, P. A., Kaczmarek, R., Mantovani, L., McLaughlin, P., Nanayakkara, L., Petrini, P., Sannié, T., Laane, E. & 6 others, Maia, R., Dettoraki, A., Farrell, A., Halimeh, S., Raza, S. & Taylor, S., 2017 Jan 1, In : European Journal of Haematology. 98, s85, p. 1-15 15 p.

    Research output: Contribution to journalArticle

  20. Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register

    Söderlund, S., Dahlén, T., Sandin, F., Olsson-Strömberg, U., Creignou, M., Dreimane, A., Lübking, A., Markevärn, B., Själander, A., Wadenvik, H., Stenke, L., Johan Richter & Höglund, M., 2017 Jan, In : European Journal of Haematology. 98, 1, p. 57-66

    Research output: Contribution to journalArticle

  21. Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing

    Malmberg, E. B. R., Ståhlman, S., Rehammar, A., Samuelsson, T., Alm, S. J., Kristiansson, E., Abrahamsson, J., Garelius, H., Louise Pettersson, Mats Ehinger, Palmqvist, L. & Fogelstrand, L., 2017 Jan, In : European Journal of Haematology. 98, 1, p. 26-37

    Research output: Contribution to journalArticle

  22. Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia: A population-based study from the Swedish AML registry

    Lj Lazarevic, V., Aldana Rosso, Gunnar Juliusson, Antunovic, P., Derolf, Å. R., Deneberg, S., Möllgård, L., Uggla, B., Wennström, L., Wahlin, A., Höglund, M., Lehmann, S. & Bertil Johansson, 2017, In : European Journal of Haematology. 98, 5, p. 493-500

    Research output: Contribution to journalArticle

  23. Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib

    Niklas Landberg, Dreimane, A., Rissler, M., Billström, R. & Helena Ågerstam, 2017, In : European Journal of Haematology. 99, 5, p. 442-448 7 p.

    Research output: Contribution to journalArticle

  24. The impact of socio-economic factors on treatment choice and mortality in chronic myeloid leukaemia

    Larfors, G., Sandin, F., Johan Richter, Själander, A., Stenke, L., Lambe, M. & Höglund, M., 2017, In : European Journal of Haematology. 98, 4, p. 398-406 9 p.

    Research output: Contribution to journalArticle

  25. Von Willebrand disease - the 'Dos' and 'Don'ts' in surgery

    Miesbach, W. & Erik Berntorp, 2017, In : European Journal of Haematology. 98, 2, p. 121-127

    Research output: Contribution to journalArticle

  26. 2016
  27. Partnering to change the world for people with haemophilia: 6th Haemophilia Global Summit, Prague, Czech Republic, 24–26th September 2015

    Jan Astermark, Hart, D., Lobet, S., Blatný, J., d'Oiron, R., Kenet, G., Dolan, G., Libotte, V. & Hermans, C., 2016 Jul 1, In : European Journal of Haematology. 97, p. 3-23 21 p.

    Research output: Contribution to journalPublished meeting abstract

  28. The first Team Haemophilia Education meeting, 2015, Amsterdam, The Netherlands

    Erik Berntorp, Hart, D., Mancuso, M. E., d'Oiron, R., Perry, D., O'Mahony, B., Kaczmarek, R., Crato, M., Pasi, J., Miners, A., Katarina Steen Carlsson, Kitchen, S., Boehlen, F., Giangrande, P., Cebura, E., Uitslager, N., Mehdi Osooli, Janeckova, D., Haldon, R. & Rivolta, G. F., 2016 Jul 1, In : European Journal of Haematology. 97, p. 3-18 16 p.

    Research output: Contribution to journalArticle

  29. Enteric-coated mycophenolate sodium could be an alternative to methotrexate for GVHD prophylaxis.

    Lazarevic, V., 2016, In : European Journal of Haematology. 97, 3, p. 213-214

    Research output: Contribution to journalDebate/Note/Editorial

  30. Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence.

    Gunnarsson, N., Sandin, F., Höglund, M., Stenke, L., Björkholm, M., Lambe, M., Olsson-Strömberg, U., Johan Richter & Själander, A., 2016, In : European Journal of Haematology. 97, 4, p. 387-392

    Research output: Contribution to journalArticle

  31. 2015
  32. Comorbidities and inhibitors in adult patients with haemophilia: issues, costs and management strategies.

    Erik Berntorp, Mauser-Bunschoten, E., Jiménez-Yuste, V. & Spears, J. B., 2015, In : European Journal of Haematology. 95, p. 1-15

    Research output: Contribution to journalReview article

  33. Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)

    Hjorth-Hansen, H., Stenke, L., Soderlund, S., Dreimane, A., Hans Ehrencrona, Gedde-Dahl, T., Gjertsen, B. T., Hoglund, M., Koskenvesa, P., Lotfi, K., Majeed, W., Markevarn, B., Ohm, L., Olsson-Stromberg, U., Remes, K., Suominen, M., Simonsson, B., Porkka, K., Mustjoki, S. & Johan Richter, 2015, In : European Journal of Haematology. 94, 3, p. 243-250

    Research output: Contribution to journalArticle

  34. Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population-based series of acute myeloid leukaemia.

    Lazarevic, V., Hörstedt, A., Bertil Johansson, Antunovic, P., Billström, R., Derolf, A., Lehmann, S., Möllgård, L., Peterson, S., Stockelberg, D., Uggla, B., Vennström, L., Wahlin, A., Höglund, M. & Gunnar Juliusson, 2015, In : European Journal of Haematology. 94, 5, p. 419-423

    Research output: Contribution to journalArticle

  35. Genetic risk factors for inhibitors in haemophilia A

    Bardi, E. & Jan Astermark, 2015, In : European Journal of Haematology. 94, p. 7-10

    Research output: Contribution to journalReview article

  36. Interaction between VWF and FVIII in treating VWD

    Miesbach, W. & Erik Berntorp, 2015, In : European Journal of Haematology. 95, 5, p. 449-454

    Research output: Contribution to journalArticle

  37. Introduction.

    Erik Berntorp, 2015, In : European Journal of Haematology. 94, p. 1-1

    Research output: Contribution to journalDebate/Note/Editorial

  38. Non-genetic risk factors and their influence on the management of patients in the clinic

    Alvarez, T., Soto, I. & Jan Astermark, 2015, In : European Journal of Haematology. 94, p. 2-6

    Research output: Contribution to journalReview article

  39. One-stage vs. chromogenic assays in haemophilia A

    Potgieter, J. J., Damgaard, M. & Andreas Hillarp, 2015, In : European Journal of Haematology. 94, p. 38-44

    Research output: Contribution to journalReview article

  40. Prevention and treatment of atherosclerosis in haemophilia - how to balance risk of bleeding with risk of ischaemic events

    de Raucourt, E., Roussel-Robert, V. & Eva Zetterberg, 2015, In : European Journal of Haematology. 94, p. 23-29

    Research output: Contribution to journalReview article

  41. Strategies for reducing inhibitor formation in severe haemophilia

    Tunstall, O. & Jan Astermark, 2015, In : European Journal of Haematology. 94, p. 45-50

    Research output: Contribution to journalReview article

  42. Switching treatments in haemophilia: is there a risk of inhibitor development?

    Santagostino, E., Auerswald, G., Benson, G., Dolan, G., Jimenez-Yuste, V., Lambert, T., Rolf Ljung, Morfini, M., Remor, E. & Salek, S. Z., 2015, In : European Journal of Haematology. 94, 4, p. 284-289

    Research output: Contribution to journalReview article

  43. The ageing patient with haemophilia

    Canaro, M., Goranova-Marinova, V. & Erik Berntorp, 2015, In : European Journal of Haematology. 94, p. 17-22

    Research output: Contribution to journalReview article

  44. Various regimens for prophylactic treatment of patients with haemophilia

    Schwarz, R., Rolf Ljung & Ulf Tedgård, 2015, In : European Journal of Haematology. 94, p. 11-16

    Research output: Contribution to journalReview article

  45. 2014
  46. Angiogenesis is increased in advanced haemophilic joint disease and characterized by normal pericyte coverage.

    Eva Zetterberg, Palmblad, J., Wallensten, R., Morfini, M., Melchiorre, D. & Holmström, E. M., 2014, In : European Journal of Haematology. 92, 3, p. 256-262

    Research output: Contribution to journalArticle

  47. High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden

    Kozlowski, P., Astrom, M., Ahlberg, L., Bernell, P., Hulegardh, E., Hagglund, H., Karlsson, K., Markuszewska-Kuczymska, A., Tomaszewska-Toporska, B., Smedmyr, B., Amini, R-M. & Hallbook, H., 2014, In : European Journal of Haematology. 92, 5, p. 377-381

    Research output: Contribution to journalArticle

  48. Immunosuppressive agents in the treatment of inhibitors in congenital haemophilia A and B - a systematic literature review

    Laros-van Gorkom, B. A. P., Falaise, C. & Jan Astermark, 2014, In : European Journal of Haematology. 93, p. 26-38

    Research output: Contribution to journalReview article

  49. Methods for individualising factor VIII dosing in prophylaxis

    Ar, M. C., Vaide, I., Erik Berntorp & Bjorkman, S., 2014, In : European Journal of Haematology. 93, p. 16-20

    Research output: Contribution to journalReview article

  50. On-demand treatment in persons with severe haemophilia

    Trakymiene, S. S. & Katarina Steen Carlsson, 2014, In : European Journal of Haematology. 93, p. 39-47

    Research output: Contribution to journalReview article

Previous 1 2 3 Next